QbD for Small-Molecule Continuous Process Development.
| Published in: | Pharmaceutical Technology Europe Vol. 36; no. 2; pp. 15 - 19 |
|---|---|
| Main Author: | |
| Format: | pictorial Journal Article |
| Published: |
MJH Life Sciences
Feb2024
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175597879&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 175597879 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Feb2024 vid: 36 iid: 2 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 175597879 175597879 175597879 175597879 ppf: 15 ppct: 4 formats: fmt: @attributes: type: P tig: atl: QbD for Small-Molecule Continuous Process Development. aug: au: Challener, Cynthia A. sug: subj: Drug Design Small Molecules United States Food and Drug Administration COVID-19 Pandemic Pharmaceutical Companies Patient Safety Drug Efficacy Technology pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|